- Traders attribute Bitcoin sell-off to thin volume, not panic selling
- US Stock Futures Climb, Oil Prices Plunge; Nonfarm Payrolls and Major Earnings Await in the Coming Week
- High Prices Push for Tax Cuts! Japan Plans to Significantly Lower Food Consumption Tax, Raising Fiscal and Inflation Risks
- Eli Lilly (LLY.US): Pancreatic cancer therapy receives breakthrough therapy designation.
- Tesla's registrations in July soared by 86% in France and 52% in Denmark, but plummeted by 97% in Norway, dropped by 81% in Spain, and fell by 60% in Sweden. Investors are awaiting registration data from Germany and the UK, which will be released later this week.
- European bond yields fall as oil prices retreat, Iran negotiation prospects boost risk sentiment
- BP to Announce Quarterly Results, Trading Division Expected to Maintain Strong Performance Amid Volatile Markets
- The US and Japan Join Forces to Intervene in the Yen: Can This Rare Collaboration Reverse Its Weak Trend?
- Marriott Leans on Conversions For Record Room Pipeline -- Market Talk
- US Treasuries rebound as geopolitical tensions ease, but rising real yields signal hidden tightening risks
- Lufthansa Q2 Earnings Preview: Impact of Iran Conflict in Focus
- Coldcard wallets drained in four attack waves so far
- Tyson Foods 3Q Prepared Foods Sales Volume Up 0.1% >TSN
- Tyson Foods 3Q Pork Sales Volume Up 5.2% >TSN
- Tyson Foods 3Q Chicken Sales Volume Up 1% >TSN
- Tyson Foods 3Q Beef Sales Volume Down 15.9% >TSN
- Tyson Foods 3Q Net $182M >TSN
- Tyson Foods Expect FY26 Free Cash Flow $1.3B - $1.7B
- Ripple Makes Critical Move for XRP: Two More Huge Investments Made!
- AI chip production capacity anxiety eased! ASML's core supplier Zeiss: Confident in meeting demand, starts headquarters expansion and new factory construction
- Luckin Coffee Q2 Revenue Up 28.5% Year-on-Year, Monthly Average Transaction Customers Reach Record High, Same-Store Sales Down 5.3% | Earnings Report Highlights
- Brazil Central Bank Survey: Economists Slightly Lower 2027 GDP Growth Forecast to 1.57%
- ICE London cocoa futures rose by more than 4%, trading at £4,201 per ton.
- The central bank of Kazakhstan stated that it sold foreign exchange worth 374 billion tenge in July to match its gold purchases; it will continue to sell foreign exchange worth 374 billion tenge in August.
- Tyson Foods Sees FY26 Total Co Adj Operating Income $2.1B-$2.3B
- Tyson Foods Sees FY26 Sales Up 2.5% to 3.5% Vs FY25 >TSN
- Ethereum ETFs Post Best Month Since October 2025 but Fed Hold Chills Demand
- Tyson Foods 3Q Operating Income $362M
- Tyson Foods 3Q Sales $13.87B >TSN
- Tyson Foods 3Q EPS 52c >TSN
- Tyson Foods 3Q Adj EPS 99c >TSN
- Tokenized TradFi credit keeps 68% of buyers after a year, while crypto-native products hemorrhage interest
- Lantheus: Combined Co Would Serve Oncology, Neurology, Cardiology Patients Across More Than 70 Countries >LNTH
- Lindblad Expeditions Sees 2026 Adjusted Ebitda $130M-$140M >LIND
- Lindblad Expeditions Sees 2026 Tour Revenue $830M-$860M >LIND
- Lantheus: Payment of CVRs Subject to Achievement of Specified Comml Milestones for Co's Products Through 2030 >LNTH
- Lindblad Expeditions 2Q Occupancy 91% >LIND
- Lantheus: Transaction Represents Total Per Shr Consideration of Up to $114.50, Total Transaction Value of Up to About $8B >LNTH
- Lantheus: Curium US to Acquire Lantheus for $102.50/Shr in Cash at Closing, Plus Non-Transferable CVRs Providing for Up to $12/Shr in Potential Additional Cash Payments >LNTH
- Curium Announces Definitive Agreement to Merge With Lantheus >LNTH
- UBS Group: Lowers Philips’ target price from 32.5 euros to 24 euros.
- Lindblad Expeditions 2Q Rev $199.2M >LIND
- Lindblad Expeditions 2Q Loss/Shr 2c >LIND
- Lindblad Expeditions 2Q Loss $1.41M >LIND
- Federal Reserve: Data driven rate path – HSBC
- The US and Iran offer conflicting statements as negotiations reach a stalemate, leaving the future of the Hormuz Agreement uncertain.
- According to the latest panel industry analysis by Trend Force, as production capacity continues to shrink and the industrial landscape shifts, it is estimated that by 2028, the combined supply share of Innolux and AUO in LCD monitor panels will fall below 10%, while the supply of LCD laptop panels will continue to decrease to nearly 20%. The supply ratio of LCD TV panels, as they still remain profitable, is expected to remain around 22%. The recent series of capacity reductions and asset optim
- Algorand Eyes Recovery as Post-Quantum Roadmap Boosts Sentiment—Can ALGO Price Break Above $0.1?
- Cardano Repeats Historic Bull Market Structure as Analyst Eyes Over 1,300% Upside to $2.9
- XRP Maintains Controlled Correction as Historical Pattern Suggests Major Weekly Rally Ahead
- Philips Target Cut to EUR24 From EUR32.50 by UBS
- Truist Securities upgrades Corning to Buy with $175 price target, citing AI-driven optical demand
- Twist Bioscience Sees 4Q Rev $123M-$124M >TWST
- Bitcoin price prediction: Market conditions improve, but BTC needs THIS for a rally
- Twist Bioscience Raises FY26 View To Rev $456M-$457M >TWST
- Twist Bioscience 3Q Research and Development Expenses $18M >TWST
- Twist Bioscience 3Q Loss/Shr 56c >TWST
- Twist Bioscience 3Q Rev $118.4M >TWST
- Luckin Coffee Q2 net revenue reached 15.89 billion RMB, up 29% year-over-year, exceeding the estimated 15.43 billion RMB. Q2 net profit was 1.49 billion RMB, a year-over-year increase of 19%. Adjusted net earnings per ADS for Q2 were 5.44 RMB.
- Bernstein raises Apple (AAPL.US) target price from $350 to $370.
- Public Policy Holding: Future Earnout Payments Could Be Made With the Final Payment Taking Place After the End of 2030 >PPHC
- Public Policy Holding: Future Earnout Payments Contingent on TAP Delivering Profit Growth Between 2026 and 2030 >PPHC
- Public Policy Holding: Such Future Payments to Be Satisfied by Mix of Cash and Equity, and Maximum Amount Payable Is $54.6M >PPHC
- Public Policy Holding: Initial Consideration Paid in Part Via Issuance of Shrs, Totaling $2.04M; Balance of $18.36M Paid in Cash, Funded From Co's Balance Sheet >PPHC
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- Public Policy Holding: Initial Consideration of $20.4M Was Satisfied on Completion, Which Occurred Aug 1 >PPHC
- Public Policy Holding: For Yr Ended Dec 31, 2025, TAP Reported Net Rev of $9.5M >PPHC
- Public Policy Holding Says Acquisition Is Immediately Earnings Accretive >PPHC
- TG Therapeutics Raises 2026 Target BRIUMVI U.S. Net Product Revenue to About $890-$905 Million >TGTX
- Avista 2Q Adj EPS 29c >AVA
- TG Therapeutics Raises 2026 View To Rev $950M >TGTX
- Marriott Sees 2026 Worldwide RevPAR Up 3%-3.5% >MAR
- Avista 2Q EPS 43c >AVA
- Marriott 2Q Adjusted Ebitda $1.59B >MAR
- TG Therapeutics 2Q Rev $240.3M >TGTX
- Air Industries: Parties to Extend Outside Date by 60 Days, Nov 30 >AIRI
- Bristol Myers Squibb Investors Might Question Potential AstraZeneca Deal -- Market Talk
- Marriott Sees 3Q Worldwide RevPAR Up 3.5%-4% >MAR
- Air Industries Group: Completing Review Process Will Likely Prevent Merger From Being Closed by Sept 30 >AIRI
- Marriott Sees 2026 Net Rooms Growth at Low End of 4.5%-5% >MAR
- Krystal Biotech 2Q Rev $119.2M >KRYS
- Marriott Sees 2026 Adjusted Ebitda $5.965B-$6.025B >MAR
- Marriott Sees 2026 Investment Spending $1.25B-$1.35B >MAR
- Seaport Therapeutics 2Q Research and Development Expenses Were $24.6M >SPTX
- Seaport Therapeutics 2Q Loss/Shr $1.78 >SPTX
- Marriott Sees 3Q Adjusted Ebitda $1.44B-$1.47B >MAR
- Marriott 2Q Comparable System-Wide Intl Constant Dollar RevPAR Down 0.5% >MAR
- Dow Jones Top Financial Services Headlines at 7 AM ET: Fed's Barkin Says It's a 'Close Call' Whether Rates Are High Enough | Three ...
- Marriott Sees FY Adj EPS $11.64-Adj EPS $11.81 >MAR
- Marriott Sees 3Q Adj EPS $2.74-Adj EPS $2.82 >MAR
- Marriott 2Q Rev $7.07B >MAR
- Marriott 2Q Comparable System-Wide Worldwide Constant Dollar RevPAR Up 3.4% >MAR
- Marriott 2Q Net $766M >MAR
- Marriott 2Q Comparable System-Wide U.S. & Canada Constant Dollar RevPAR Up 5.0% >MAR
- Ocular Therapeutix 2Q Loss $78.8M >OCUL
- Ocular Therapeutix 2Q Loss/Shr 35c >OCUL
- BCB Bancorp 2Q Loss/Shr 85c >BCBP
